首页> 外文期刊>Trends in Ecology & Evolution >Did the Medicare Prescription Drug Program Lead to New Racial and Ethnic Disparities? Examining Long-term Changes in Prescription Drug Access among Minority Populations
【24h】

Did the Medicare Prescription Drug Program Lead to New Racial and Ethnic Disparities? Examining Long-term Changes in Prescription Drug Access among Minority Populations

机译:Medicare处方药计划是否导致新的种族和族裔差异? 检查少数民族人口中处方药物的长期变化

获取原文
获取原文并翻译 | 示例
           

摘要

This study examined whether the Medicare Part D program was associated with racial/ethnic disparities in prescription drug access among elderly individuals who reported adequate access to physicians. Using a population-based survey of New Jersey residents, a difference-in-differences model estimated elderly blacks (OR = 3.20;p= .05) and Hispanics (OR = 4.29;p= .05) had higher odds than whites of reporting prescription access problems in the post, but not the pre-Part D period. The presence of prescription insurance did not lead to a significant decrease in access problems. Part D beneficiaries are required to make complicated decisions on cost-sharing and medication choices that require active involvement by physicians and pharmacists. Lack of guidance may critically impact minorities and economically vulnerable patients and cannot be addressed by extending coverage alone.
机译:本研究审查了医疗保险部分D计划是否与报告充分获得医生的老年人处方药中的处方药物进入的种族/族裔差异。 利用基于人口对新泽西居民的调查,差异差异模型估计的老年黑人(或= 3.20; p = .05)和西班牙裔(或= 4.29; p = .05)的赔率高于报告的白人 处方访问问题在帖子中,但不是前一段。 处方保险的存在不会导致获得问题的显着下降。 第D部分受益人需要对需要受到医生和药剂师的成本共享和药物选择的复杂决定进行复杂的决定。 缺乏指导可能批判性地影响少数群体和经济弱势伤害的患者,并且不能仅通过仅扩展覆盖范围来解决。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号